( 09688.hk)
市盈率-10.20市净率4.14市销率7.77股息率0.00%上市时间2020-09-28股价19.76港币 (-3.61% , 7,999.01万港币) 市值214.65亿港币总股本10.86亿上市至今年化投资收益率-24.37%港股通持仓占H股比例9.17%累计做空占H股本比2.22%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
所属指数指数纳入纳出
备注 (1): 双击编辑备注
发表讨论

再鼎医药(09688) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1VOUNATSOS Michel PericlesIndependent Non Executive Director2023-01-09--
2GAYNOR Richard BrianIndependent Non Executive Director2021-11-19--
3MORRISON Scott WilliamIndependent Non Executive Director2021-10-13--
4梁頴宇Independent Non Executive Director2020-07-01--
5MOULDER JR Leon OliverIndependent Non Executive Director2020-01-01--
6LIS William DavidIndependent Non Executive Director2018-10-01--
7陳凱先Independent Non Executive Director2018-08-01--
8DIEKMAN John DavidIndependent Non Executive Director2017-08-01--
9傅濤Executive Director2017-08-012021-05-07
10WIRTH Peter KarlIndependent Non Executive Director2017-06-01--
11杜瑩Executive DirectorChairman, CEO2013-03-01--